Welcome to our dedicated page for Cactus Acquisition 1 SEC filings (Ticker: CCTSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trust-fund mechanics, Extension deadlines, and potential merger clues make Cactus Acquisition Corp 1 Ltd’s SEC filings anything but straightforward. Whether you’re tracking how much cash remains in the trust or curious about Israel-focused healthcare targets, digging through 8-Ks and proxy supplements can be daunting.
Stock Titan’s AI steps in to translate those opaque disclosures into clear takeaways. Our platform delivers Cactus Acquisition Corp 1 Ltd insider trading Form 4 transactions in real time, surfaces red-flag clauses from each 8-K material event, and condenses every Cactus Acquisition Corp 1 Ltd quarterly earnings report 10-Q filing into plain-English highlights. Need the big picture fast? Try our one-page overview that turns a 300-page prospectus into key numbers on trust balance, redemption ratios, and sponsor risk—perfect for understanding Cactus Acquisition Corp 1 Ltd SEC documents with AI.
From monitoring Cactus Acquisition Corp 1 Ltd Form 4 insider transactions real-time before a vote, to consulting our AI-driven notes on the next Cactus Acquisition Corp 1 Ltd 8-K material events explained, we connect each form to what matters: merger progress, sponsor incentives, and shareholder dilution. You’ll also find links to the Cactus Acquisition Corp 1 Ltd annual report 10-K simplified, detailed Cactus Acquisition Corp 1 Ltd proxy statement executive compensation analyses, and side-by-side trend charts for every quarter. Stop wading through legal jargon—our AI summaries, real-time alerts, and historical comparisons turn complex filings into actionable insights.
Cactus Acquisition Corp. 1 Limited Warrant (CCTSW) is asking shareholders to approve two proposals at an upcoming meeting. Proposal No. 1 seeks a special-resolution amendment to the company’s amended and restated memorandum and articles of association to extend the deadline to complete an initial business combination from November 2, 2025 to November 2, 2026, while allowing the board the discretion to wind up operations earlier. Proposal No. 2 is an ordinary-resolution request to permit adjournment of the meeting if further solicitation of proxies is needed for Proposal No. 1. The board recommends a vote FOR both proposals. The proxy material discloses security ownership: Cactus Healthcare Management LP holds 632,500 shares (16.11%), and several named individuals were assigned founder shares in specific amounts by the sponsor.
Kepos Capital LP and Mark Carhart report beneficial ownership of 200,000 Class A ordinary shares of Cactus Acquisition Corp. 1 Ltd, representing 5.1% of the outstanding Class A shares used in the filing calculation. The shares are held by funds managed by Kepos and are reported as held in the ordinary course of business; the filing states they were not acquired to change or influence control. The disclosure shows shared voting and dispositive power of 200,000 shares and identifies Kepos Special Opportunities Master Fund L.P. as holding more than 5% economic interest.
Cactus Acquisition Corp. 1 Limited is a blank check company formed to complete an initial business combination. As of March 31, 2025, the unaudited condensed balance sheet shows $21 (in thousands) of cash, $9,075 (in thousands) held in the trust account, and a total capital deficiency of $(2,242) (in thousands). For the three months ended March 31, 2025 the company reported a net loss of $(78) (in thousands) and interest income of $95 (in thousands) on trust investments.
The company has a signed Business Combination Agreement with Tembo e-LV B.V. under which Tembo equity holders would receive $838 million in newly issued shares valued at $10.00 per share; closing remains subject to regulatory approvals, audited financials, shareholder approval and SEC review of a Form F-4. Trading was suspended on Nasdaq and the company commenced trading on the OTC market under the symbol CCTSF. The company obtained a third extension of its combination deadline to November 2, 2025.
The filing discloses substantial doubt about the company’s ability to continue as a going concern, related-party and third-party promissory notes (including a $600,000 note with Energi with a balance of $646,000 as of March 31, 2025 and a sponsor loan balance of $780,000), and a material weakness in internal control over accounting for founder share assignments and insufficient finance personnel. A subsequent unsecured promissory note of $200,000 was issued on July 17, 2025.